About Us
Our Company
Management & Board
Aceragen
Tilsotolimod
Toll-Like Receptor Activation
Publications & Presentations
Investor Relations
×
Analysis of Real-World Oral Prednisone Usage in Patients with Dermatomyositis Supports the Unmet Need for Additional Corticosteroid-Sparing Agents